BALAMINES

Balaji Amines Share Price

₹1,982.00 -13.6 (-0.68%)

21 Nov, 2024 13:58

SIP TrendupStart SIP in BALAMINES

Start SIP

Performance

  • Low
  • ₹1,973
  • High
  • ₹1,998
  • 52 Week Low
  • ₹1,950
  • 52 Week High
  • ₹2,735
  • Open Price₹1,985
  • Previous Close₹1,996
  • Volume19,335

Investment Returns

  • Over 1 Month -8.81%
  • Over 3 Month -7.88%
  • Over 6 Month -12.97%
  • Over 1 Year -2.35%
SIP Lightning

Smart Investing Starts Here Start SIP with Balaji Amines for Steady Growth!

Invest Now

Balaji Amines Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 31.8
  • PEG Ratio
  • 14.5
  • Market Cap Cr
  • 6,422
  • P/B Ratio
  • 3.4
  • Average True Range
  • 62.37
  • EPS
  • 62.24
  • Dividend Yield
  • 0.6
  • MACD Signal
  • -41.75
  • RSI
  • 36.38
  • MFI
  • 38.69

Balaji Amines Financials

Balaji Amines Technicals

EMA & SMA

Current Price
₹1,982.00
-13.6 (-0.68%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹2,076.52
  • 50 Day
  • ₹2,146.01
  • 100 Day
  • ₹2,190.80
  • 200 Day
  • ₹2,223.87

Resistance and Support

2003.37 Pivot Speed
  • R3 2,076.73
  • R2 2,054.87
  • R1 2,025.23
  • S1 1,973.73
  • S2 1,951.87
  • S3 1,922.23

What's your outlook on Balaji Amines?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Balaji Amines Ltd., is a leading ISO 9001:2015 certified manufacturer of Methylamines, Ethylamines, Specialty Chemicals, and Pharma Excipients. The company is renowned for its advanced manufacturing and R&D capabilities.

Balaji Amines Limited has an operating revenue of Rs. 1,528.92 Cr. on a trailing 12-month basis. An annual revenue de-growth of -30% needs improvement, Pre-tax margin of 18% is great, ROE of 11% is good. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 52 which is a POOR score indicating inconsistency in earnings, a RS Rating of 27 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 76 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Balaji Amines Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-08-07 Quarterly Results
2024-05-08 Audited Results & Final Dividend
2024-01-31 Quarterly Results
2023-11-08 Quarterly Results

Balaji Amines F&O

Balaji Amines Shareholding Pattern

53.7%
0.14%
1.52%
5.27%
0%
34.07%
5.3%

About Balaji Amines

  • NSE Symbol
  • BALAMINES
  • BSE Symbol
  • 530999
  • Managing Director
  • Mr. D Ram Reddy
  • ISIN
  • INE050E01027

Similar Stocks to Balaji Amines

Balaji Amines FAQs

Balaji Amines share price is ₹1,982 As on 21 November, 2024 | 13:44

The Market Cap of Balaji Amines is ₹6421.9 Cr As on 21 November, 2024 | 13:44

The P/E ratio of Balaji Amines is 31.8 As on 21 November, 2024 | 13:44

The PB ratio of Balaji Amines is 3.4 As on 21 November, 2024 | 13:44

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23